HCAT
Health Catalyst·NASDAQ
--
--(--)
--
--(--)
6.36 / 10
Outperform
HCAT's fundamental profile is decent (score 6.4/10). Key strengths include a healthy asset-liability ratio of 43.47% and an equity multiplier of 1.769, both in performance group 2 or higher. However, operating revenue growth is only moderate at 4.18% YoY, and ROE has deteriorated by -24.23% YoY, placing these factors in lower groups. Overall, the fundamentals are satisfactory but not compelling, warranting monitoring for improvement.
Analysis Checks(3/10)
Asset-liability ratio (%)
Value43.47
Score2/3
Weight32.16%
1M Return2.31%
Value43.47
Score2/3
Weight32.16%
1M Return2.31%
Equity multiplier
Value1.77
Score2/3
Weight42.61%
1M Return3.03%
Value1.77
Score2/3
Weight42.61%
1M Return3.03%
Equity ratio (Total liabilities / Shareholders’ equity attributable to parent company) (%)
Value0.77
Score2/3
Weight36.42%
1M Return2.63%
Value0.77
Score2/3
Weight36.42%
1M Return2.63%
Current assets turnover ratio
Value0.75
Score0/3
Weight-19.78%
1M Return-1.65%
Value0.75
Score0/3
Weight-19.78%
1M Return-1.65%
Total assets turnover ratio
Value0.33
Score0/3
Weight-14.20%
1M Return-1.15%
Value0.33
Score0/3
Weight-14.20%
1M Return-1.15%
Total operating revenue (YoY growth rate %)
Value4.18
Score1/3
Weight5.36%
1M Return0.37%
Value4.18
Score1/3
Weight5.36%
1M Return0.37%
ROE (diluted) (YoY growth rate %)
Value-24.23
Score0/3
Weight-21.51%
1M Return-1.90%
Value-24.23
Score0/3
Weight-21.51%
1M Return-1.90%
Total profit / EBIT (%)
Value100.00
Score1/3
Weight23.50%
1M Return1.76%
Value100.00
Score1/3
Weight23.50%
1M Return1.76%
Operating revenue (YoY growth rate %)
Value4.18
Score1/3
Weight6.41%
1M Return0.45%
Value4.18
Score1/3
Weight6.41%
1M Return0.45%
Current ratio
Value1.88
Score1/3
Weight9.03%
1M Return0.64%
Value1.88
Score1/3
Weight9.03%
1M Return0.64%
Asset-liability ratio (%)
Value43.47
Score2/3
Weight32.16%
1M Return2.31%
Value43.47
Score2/3
Weight32.16%
1M Return2.31%
Total operating revenue (YoY growth rate %)
Value4.18
Score1/3
Weight5.36%
1M Return0.37%
Value4.18
Score1/3
Weight5.36%
1M Return0.37%
Equity multiplier
Value1.77
Score2/3
Weight42.61%
1M Return3.03%
Value1.77
Score2/3
Weight42.61%
1M Return3.03%
ROE (diluted) (YoY growth rate %)
Value-24.23
Score0/3
Weight-21.51%
1M Return-1.90%
Value-24.23
Score0/3
Weight-21.51%
1M Return-1.90%
Equity ratio (Total liabilities / Shareholders’ equity attributable to parent company) (%)
Value0.77
Score2/3
Weight36.42%
1M Return2.63%
Value0.77
Score2/3
Weight36.42%
1M Return2.63%
Total profit / EBIT (%)
Value100.00
Score1/3
Weight23.50%
1M Return1.76%
Value100.00
Score1/3
Weight23.50%
1M Return1.76%
Current assets turnover ratio
Value0.75
Score0/3
Weight-19.78%
1M Return-1.65%
Value0.75
Score0/3
Weight-19.78%
1M Return-1.65%
Operating revenue (YoY growth rate %)
Value4.18
Score1/3
Weight6.41%
1M Return0.45%
Value4.18
Score1/3
Weight6.41%
1M Return0.45%
Total assets turnover ratio
Value0.33
Score0/3
Weight-14.20%
1M Return-1.15%
Value0.33
Score0/3
Weight-14.20%
1M Return-1.15%
Current ratio
Value1.88
Score1/3
Weight9.03%
1M Return0.64%
Value1.88
Score1/3
Weight9.03%
1M Return0.64%
Is HCAT undervalued or overvalued?
- HCAT scores 6.36/10 on fundamentals and holds a Discounted valuation at present. Backed by its -24.94% ROE, -34.05% net margin, -1.41 P/E ratio, 0.46 P/B ratio, and -17.91% earnings growth, these metrics solidify its Outperform investment rating.
